Press Release | ImmuneMed

Press Release

Total 9, 1/2 Page

게시판 리스트
No. Subject Writer Date of Preparation Views
9 [Journal of Clinical Medicine] COVID-19 Phase 2 Clinical Study Results
  • ImmuneMed
  • 2022-05-26
ImmuneMed 2022-05-26 8841
8 [Heliyon] hzVSF inhibits hepatitis B virus infection by targeting viral cell entry
  • ImmuneMed
  • 2022-05-26
ImmuneMed 2022-05-26 8416
7 [Press Release] ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate
development of the treatment
  • ImmuneMed
  • 2021-01-08
ImmuneMed 2021-01-08 6398
6 COVID-19 Phase 2 Clinical Study Approval (Italy), December 18th, 2020
  • ImmuneMed
  • 2020-12-21
ImmuneMed 2020-12-21 6177
5 Obtaining Approval Letter of Investigational New Drug (IND) for COVID-19 Phase 2
Study in Republic of Korea on 7th December, 2020
  • ImmuneMed
  • 2020-12-07
ImmuneMed 2020-12-07 1295
4 COVID-19 Phase 2 Clinical Study Approval (Indonesia), December 1st, 2020
  • ImmuneMed
  • 2020-12-01
ImmuneMed 2020-12-01 5717